Ardelyx Inc (ARDX)

$5.99 +0.19 (3.28%)
Market Cap 1.41B
Revenue (ttm) 333.62M
Net Income (ttm) -39.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -11.73%
Debt to Equity Ratio 1.31
Volume 1,511,900
Avg Vol 3,395,288
Day's Range N/A - N/A
Shares Out 242.97M
Stochastic %K 46%
Beta 0.55
Analysts Strong Sell
Price Target $11.70

Company Profile

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in Ju...

Industry: Biotechnology
Sector: Healthcare
Phone: 510 745 1700
Address:
400 Fifth Avenue, Suite 210, Waltham, United States
MedHS55
MedHS55 Dec. 25 at 2:44 PM
$ARDX Merry Christmas! If anyone is looking at their computer before opening presents or ordering Chinese food, the short ratio volume was 61% which is the highest I've seen. I've attached the link from FINRA which explains what the short ratio means. https://www.finra.org/rules-guidance/notices/information-notice-051019
1 · Reply
fabio69
fabio69 Dec. 25 at 12:33 PM
$ARDX Merry Christmas to all old and new Ardx owners, especially us long-distance riders. 2026 awaits us and we hope it will reward our patience and perseverance.
0 · Reply
1iquid
1iquid Dec. 25 at 12:05 PM
💎 Liquid® Live Actionable Trade Asset: $ARDX Contracts: $ARDX January 15, 2027 $7 Calls Scale in: $1.37- $1.68 Scale out: $5.34-$9.15 Profit Potential : 100% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
AJavier
AJavier Dec. 25 at 10:34 AM
$ARDX
0 · Reply
opportoni
opportoni Dec. 25 at 8:13 AM
$ARDX Merry Christmas! The first half of 2026 will bring the decision here. The rising trendline has just been confirmed once more. Looking forward to what will our first profitable year.
1 · Reply
Andy1966
Andy1966 Dec. 25 at 7:24 AM
$ARDX Sustainably overcome (5.51), now it's time to tackle the next hurdles. 6.44 -- 6.69 -- 6.96 -- 7.30
0 · Reply
M_OF_E
M_OF_E Dec. 25 at 2:55 AM
$ARDX Short Interest up slightly Ardelyx, Inc. - Common Stock Settlement Date Short Interest Percent Change Average Daily Share Volume Days to Cover 12/15/2025 20,664,408 2.80 2,774,197 7.45 11/28/2025 20,101,736 8.26 2,656,151 7.57
0 · Reply
Cameohitch
Cameohitch Dec. 24 at 11:30 PM
$ARDX Merry Xmas, you all! I'm grateful for your company on this incredible adventure and wish you happy holidays!
0 · Reply
FerreroRocher
FerreroRocher Dec. 24 at 10:57 PM
$ARDX https://www.linkedin.com/posts/ardelyx-inc-_happyholidays-activity-7409235853014769665-hxYM?utm_source=share&utm_medium=member_android&rcm=ACoAACnfTVMBMgy_5nyoAz7_V84vI2NNRA1KuoY
0 · Reply
imlivinit
imlivinit Dec. 24 at 10:56 PM
$ARDX Wishing you all holiday times of joy, good treats and peace. A big thank you to all my friends and longs here for sharing your knowledge and support. We can welcome 2026 with our sunny-sides up because this will be a swell year—more access to Tenapanor and the healing that brings, and more financial gain for us.
0 · Reply
Latest News on ARDX
Real-World Evidence Studies of XPHOZAH® (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week

Nov 7, 2025, 4:05 PM EST - 6 weeks ago

Real-World Evidence Studies of XPHOZAH® (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week

Ardelyx to Participate at the Jefferies Global Healthcare Conference in London

Nov 5, 2025, 8:00 AM EST - 7 weeks ago

Ardelyx to Participate at the Jefferies Global Healthcare Conference in London

Ardelyx: Impressive Q3 Record Growth - Why I Buy

Nov 5, 2025, 4:24 AM EST - 7 weeks ago

Ardelyx: Impressive Q3 Record Growth - Why I Buy

Ardelyx: A Long Overdue Rally

Nov 4, 2025, 3:32 PM EST - 7 weeks ago

Ardelyx: A Long Overdue Rally

Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference

Nov 4, 2025, 8:00 AM EST - 7 weeks ago

Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference

Ardelyx, Inc. (ARDX) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 11:06 PM EDT - 7 weeks ago

Ardelyx, Inc. (ARDX) Q3 2025 Earnings Call Transcript

Ardelyx Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Oct 30, 2025, 4:01 PM EDT - 7 weeks ago

Ardelyx Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Ardelyx Presents Data that Continues to Support the Benefits of IBSRELA® (tenapanor) at the American College of Gastroenterology's 2025 Annual Meeting

Oct 28, 2025, 8:01 AM EDT - 2 months ago

Ardelyx Presents Data that Continues to Support the Benefits of IBSRELA® (tenapanor) at the American College of Gastroenterology's 2025 Annual Meeting

Ardelyx Announces Four Abstracts Accepted for Poster Presentations at the American Society of Nephrology's Kidney Week

Oct 21, 2025, 8:00 AM EDT - 2 months ago

Ardelyx Announces Four Abstracts Accepted for Poster Presentations at the American Society of Nephrology's Kidney Week

Ardelyx to Report Third Quarter 2025 Financial Results on October 30, 2025

Oct 13, 2025, 8:35 AM EDT - 2 months ago

Ardelyx to Report Third Quarter 2025 Financial Results on October 30, 2025

Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial Officer

Oct 13, 2025, 8:30 AM EDT - 2 months ago

Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial Officer

Ardelyx, Inc. (ARDX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 8, 2025, 10:11 AM EDT - 3 months ago

Ardelyx, Inc. (ARDX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Ardelyx, Inc. (ARDX) Presents At Citi's Biopharma Back To School Conference Transcript

Sep 3, 2025, 4:42 PM EDT - 4 months ago

Ardelyx, Inc. (ARDX) Presents At Citi's Biopharma Back To School Conference Transcript

Ardelyx to Participate in Upcoming Investor Conferences

Aug 25, 2025, 8:00 AM EDT - 4 months ago

Ardelyx to Participate in Upcoming Investor Conferences

Ardelyx: Improved Outlook For Ibsrela And Xphozah

Aug 15, 2025, 6:17 AM EDT - 4 months ago

Ardelyx: Improved Outlook For Ibsrela And Xphozah

Ardelyx, Inc. (ARDX) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 8:11 PM EDT - 5 months ago

Ardelyx, Inc. (ARDX) Q2 2025 Earnings Call Transcript

Ardelyx Announces Changes to the Executive Leadership Team

Aug 4, 2025, 4:08 PM EDT - 5 months ago

Ardelyx Announces Changes to the Executive Leadership Team

Ardelyx Reports Second Quarter 2025 Financial Results and Provides Business Update

Aug 4, 2025, 4:01 PM EDT - 5 months ago

Ardelyx Reports Second Quarter 2025 Financial Results and Provides Business Update

Ardelyx to Report Second Quarter 2025 Financial Results on August 4, 2025

Jul 21, 2025, 8:00 AM EDT - 5 months ago

Ardelyx to Report Second Quarter 2025 Financial Results on August 4, 2025

Ardelyx Appoints Mike Kelliher Chief Business Officer and James P. Brady Chief Human Resources Officer

Jun 2, 2025, 4:05 PM EDT - 7 months ago

Ardelyx Appoints Mike Kelliher Chief Business Officer and James P. Brady Chief Human Resources Officer

Ardelyx to Participate at the Jefferies Global Healthcare Conference 2025

May 21, 2025, 8:00 AM EDT - 7 months ago

Ardelyx to Participate at the Jefferies Global Healthcare Conference 2025

Ardelyx Presents Data Supporting IBSRELA® (tenapanor) at Digestive Disease Week 2025 Conference

May 6, 2025, 8:01 AM EDT - 8 months ago

Ardelyx Presents Data Supporting IBSRELA® (tenapanor) at Digestive Disease Week 2025 Conference

Ardelyx: Revenue Misses And Losses Widen Amid XPHOZAH Uncertainty

May 2, 2025, 10:07 AM EDT - 8 months ago

Ardelyx: Revenue Misses And Losses Widen Amid XPHOZAH Uncertainty

Ardelyx, Inc. (ARDX) Q1 2025 Earnings Call Transcript

May 1, 2025, 10:06 PM EDT - 8 months ago

Ardelyx, Inc. (ARDX) Q1 2025 Earnings Call Transcript

Ardelyx Reports First Quarter 2025 Financial Results and Provides Business Update

May 1, 2025, 4:01 PM EDT - 8 months ago

Ardelyx Reports First Quarter 2025 Financial Results and Provides Business Update

Ardelyx Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors

Apr 29, 2025, 8:00 AM EDT - 8 months ago

Ardelyx Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors

Ardelyx Announces Three Abstracts Accepted for Poster Presentations at Digestive Disease Week 2025 Conference

Apr 24, 2025, 8:01 AM EDT - 8 months ago

Ardelyx Announces Three Abstracts Accepted for Poster Presentations at Digestive Disease Week 2025 Conference

Ardelyx to Report First Quarter 2025 Financial Results on May 1, 2025

Apr 17, 2025, 8:00 AM EDT - 9 months ago

Ardelyx to Report First Quarter 2025 Financial Results on May 1, 2025

Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings

Apr 10, 2025, 4:02 PM EDT - 9 months ago

Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings

Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings

Mar 31, 2025, 4:03 PM EDT - 9 months ago

Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings

Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award

Mar 13, 2025, 8:02 AM EDT - 10 months ago

Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award

Undercovered Dozen: Ardelyx, Aviva, Nutrien, Heartland Express +

Mar 1, 2025, 8:30 AM EST - 10 months ago

Undercovered Dozen: Ardelyx, Aviva, Nutrien, Heartland Express +

HTLD NTR

Tenapanor Approved in China for Hyperphosphatemia

Feb 26, 2025, 7:00 AM EST - 10 months ago

Tenapanor Approved in China for Hyperphosphatemia

Ardelyx: Limited Pipeline, Rising Costs, And Uncertain Growth Ahead (Downgrade)

Feb 24, 2025, 2:28 PM EST - 10 months ago

Ardelyx: Limited Pipeline, Rising Costs, And Uncertain Growth Ahead (Downgrade)

3 Biotech/Healthcare Names Under $10 I Am Buying Now

Feb 21, 2025, 4:21 PM EST - 10 months ago

3 Biotech/Healthcare Names Under $10 I Am Buying Now

GERN MRNA PSNL TEM

Ardelyx, Inc. (ARDX) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 2:32 PM EST - 10 months ago

Ardelyx, Inc. (ARDX) Q4 2024 Earnings Call Transcript

Ardelyx Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Feb 20, 2025, 7:30 AM EST - 11 months ago

Ardelyx Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Ardelyx to Present at the TD Cowen 45th Annual Health Care Conference

Feb 19, 2025, 8:01 AM EST - 11 months ago

Ardelyx to Present at the TD Cowen 45th Annual Health Care Conference

Ardelyx to Report Full Year and Fourth Quarter 2024 Financial Results on February 20, 2025

Jan 30, 2025, 4:30 PM EST - 11 months ago

Ardelyx to Report Full Year and Fourth Quarter 2024 Financial Results on February 20, 2025

Ardelyx Provides Update on Increasing Commercial Momentum and 2025 Strategic Priorities

Jan 13, 2025, 8:03 AM EST - 1 year ago

Ardelyx Provides Update on Increasing Commercial Momentum and 2025 Strategic Priorities

MedHS55
MedHS55 Dec. 25 at 2:44 PM
$ARDX Merry Christmas! If anyone is looking at their computer before opening presents or ordering Chinese food, the short ratio volume was 61% which is the highest I've seen. I've attached the link from FINRA which explains what the short ratio means. https://www.finra.org/rules-guidance/notices/information-notice-051019
1 · Reply
fabio69
fabio69 Dec. 25 at 12:33 PM
$ARDX Merry Christmas to all old and new Ardx owners, especially us long-distance riders. 2026 awaits us and we hope it will reward our patience and perseverance.
0 · Reply
1iquid
1iquid Dec. 25 at 12:05 PM
💎 Liquid® Live Actionable Trade Asset: $ARDX Contracts: $ARDX January 15, 2027 $7 Calls Scale in: $1.37- $1.68 Scale out: $5.34-$9.15 Profit Potential : 100% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
AJavier
AJavier Dec. 25 at 10:34 AM
$ARDX
0 · Reply
opportoni
opportoni Dec. 25 at 8:13 AM
$ARDX Merry Christmas! The first half of 2026 will bring the decision here. The rising trendline has just been confirmed once more. Looking forward to what will our first profitable year.
1 · Reply
Andy1966
Andy1966 Dec. 25 at 7:24 AM
$ARDX Sustainably overcome (5.51), now it's time to tackle the next hurdles. 6.44 -- 6.69 -- 6.96 -- 7.30
0 · Reply
M_OF_E
M_OF_E Dec. 25 at 2:55 AM
$ARDX Short Interest up slightly Ardelyx, Inc. - Common Stock Settlement Date Short Interest Percent Change Average Daily Share Volume Days to Cover 12/15/2025 20,664,408 2.80 2,774,197 7.45 11/28/2025 20,101,736 8.26 2,656,151 7.57
0 · Reply
Cameohitch
Cameohitch Dec. 24 at 11:30 PM
$ARDX Merry Xmas, you all! I'm grateful for your company on this incredible adventure and wish you happy holidays!
0 · Reply
FerreroRocher
FerreroRocher Dec. 24 at 10:57 PM
$ARDX https://www.linkedin.com/posts/ardelyx-inc-_happyholidays-activity-7409235853014769665-hxYM?utm_source=share&utm_medium=member_android&rcm=ACoAACnfTVMBMgy_5nyoAz7_V84vI2NNRA1KuoY
0 · Reply
imlivinit
imlivinit Dec. 24 at 10:56 PM
$ARDX Wishing you all holiday times of joy, good treats and peace. A big thank you to all my friends and longs here for sharing your knowledge and support. We can welcome 2026 with our sunny-sides up because this will be a swell year—more access to Tenapanor and the healing that brings, and more financial gain for us.
0 · Reply
Memphis74
Memphis74 Dec. 24 at 9:01 PM
$ARDX HAPPY HOLIDAYS!!!! Especially to Bernard, Ferrero, Cameo, M_OF _E, Opportoni (and all those I forgot) that do DD with their research and charts (you’ve taught an old dog quite a few new tricks this year).
1 · Reply
Cartoon7
Cartoon7 Dec. 24 at 7:43 PM
$ARDX Wishing a Merry Christmas to the ARDX family
0 · Reply
Shorthand
Shorthand Dec. 24 at 7:29 PM
$ARDX
0 · Reply
ToadTrader
ToadTrader Dec. 24 at 7:07 PM
$ARDX Friday.... 0nly 43 Hrs before Market Opens...LOL Until Then... Quiet! Happy Holidays! CHEERS
0 · Reply
sunnysky10
sunnysky10 Dec. 24 at 5:05 PM
$ARDX Merry Christmas to you and yours! Here is hoping for a double digit to ARDX next year!
0 · Reply
KevinDL
KevinDL Dec. 24 at 4:13 PM
$ARDX big wall at $6.05. Let’s knock it down! Merry Christmas longs!
0 · Reply
ToadTrader
ToadTrader Dec. 24 at 4:03 PM
$ARDX Well, just saying....... The Next of my "Crazy Projection Lines" is $6.62 That would give us a 11% gain over yesterday...LOL I'm good for it... we still have about 3-Hrs to play....LOl CHEERS!
0 · Reply
Cjs2027
Cjs2027 Dec. 24 at 4:03 PM
$ARDX Happy Holidays to all of you!
0 · Reply
IMADORK
IMADORK Dec. 24 at 4:02 PM
$ARDX SP up, as some whales have been eating shares up it appears.
1 · Reply
ToadTrader
ToadTrader Dec. 24 at 3:52 PM
$ARDX @TonySoprano1987 Some days, I almost miss Tony! Where is that Drummer Boy?? CHEERS!
0 · Reply
ToadTrader
ToadTrader Dec. 24 at 3:47 PM
$ARDX You all be careful.... The Strip search for share, likely starts Friday! LOL
0 · Reply
ToadTrader
ToadTrader Dec. 24 at 3:46 PM
$ARDX Okay.... If My "Greetings" are this effective towards price running up.... I'll start posting such.... several times a day...LOL Merry Christmas!
0 · Reply